Companies

BioRestorative Therapies, Inc.

BRTX · CIK 0001505497 · operating

$0.22-5.82%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$4.62M
P/E
Fwd P/E-0.18
PEG
P/S12.05
P/B0.78
EV/EBITDA0.18
EV/Rev-6.72

Profitability

Gross Margin93.00%
Op. Margin-2881.59%
Net Margin-2239.25%
ROE-105.25%
ROA-73.12%
FCF Margin-2078.94%

Financial Health

Current Ratio2.97
Debt/Equity0.44
Free Cash Flow-$8.34M
Div. Yield

Growth & Other

Revenue Growth175.03%
EPS Growth66.08%
Beta0.24
52W High$2.1
52W Low$0.19

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. (BRTX) is a services-misc health & allied services, nec company incorporated in NV, listed on the Nasdaq. With a market capitalization of $5 million, BioRestorative Therapies, Inc. is a micro-cap company. The stock currently trades at $0.22, down 5.82% today, with a 52-week range of $0.19–$2.28.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.16$-1.16+66.1%
2023$-3.42$-3.42+33.1%
2022$-5.11
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

Annual Reports (10-K) · 14 filings

Report DateFiledAccession Number
2024-12-312025-03-280001641172-25-001011SEC ↗
2023-12-312024-04-010001493152-24-012056SEC ↗
2022-12-312023-03-270001493152-23-008960SEC ↗
2021-12-312022-03-300001493152-22-008184SEC ↗
2020-12-312021-04-300001493152-21-010062SEC ↗
2019-12-312021-03-180001493152-21-006285SEC ↗
2018-12-312019-03-290001493152-19-004292SEC ↗
2017-12-312018-04-020001493152-18-004554SEC ↗
2016-12-312017-03-220001493152-17-002701SEC ↗
2015-12-312016-03-300001144204-16-091575SEC ↗
2014-12-312015-03-310001144204-15-020255SEC ↗
2013-12-312014-04-110001144204-14-022141SEC ↗
2012-12-312013-04-020001144204-13-019421SEC ↗
2011-12-312012-04-160001144204-12-021914SEC ↗